MEDICAL THERAPY FOR ACROMEGALY
- 1 March 1999
- journal article
- review article
- Published by Elsevier in Endocrinology and Metabolism Clinics of North America
- Vol. 28 (1), 171-190
- https://doi.org/10.1016/s0889-8529(05)70062-1
Abstract
No abstract availableKeywords
This publication has 108 references indexed in Scilit:
- Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegalyJournal of Neurosurgery, 1998
- Octreotide Long-Acting Release (LAR)Drugs, 1997
- Effects of octreotide on biliary lipid composition and occurrence of cholesterol crystals in patients with acromegalyDigestive Diseases and Sciences, 1994
- Slow release lanreotide treatment in acromegalic patients previously normalized by octreotideJournal of Clinical Endocrinology & Metabolism, 1994
- AcromegalyNew England Journal of Medicine, 1990
- Hormonal effects of CV 205–502, a novel octahydrobenzo [g] quinoline with potent dopamine agonist propertiesLife Sciences, 1988
- Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1985
- Pergolide for the Treatment of Pituitary Tumors Secreting Prolactin or Growth HormoneNew England Journal of Medicine, 1983
- CHANGES IN CIRCULATING SOMATOMEDIN-C LEVELS IN BROMOCRIPTINE-TREATED ACROMEGALYClinical Endocrinology, 1982
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982